Item 7.01. Regulation FD Disclosure
On June 25, 2012, Protalix BioTherapeutics, Inc. (the "Company") issued a press
release announcing that new clinical data on ELELYSO™ will be presented at the
10th Annual European Working Group on Gaucher Disease Meeting being held June
28-30 in Paris, France, at the Novotel Paris Tour Eiffel Convention Center.
A copy of the press release is furnished as Exhibit 99.1.
The information contained in Item 7.01 of this report and in Exhibit 99.1 shall
not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), or incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such a filing.
Add
PLX to Portfolio
Set Alert
Email to a
Friend